The global healthcare landscape is increasingly focused on the management of systemic inflammatory conditions, placing the Erythema Nodosum Market at the forefront of dermatological and immunological research. As a primary clinical indicator of various underlying pathologies, the effective diagnosis and treatment of erythema nodosum (EN) are essential for comprehensive patient care. https://www.databridgemarketresearch.com/